@article{cb61d0633a6e4a418e186c03fb9bf266,
title = "Drug-eluting versus bare-metal stents in saphenous vein graft lesions",
author = "Brilakis, {Emmanouil S.} and Subhash Banerjee and Shunk, {Kendrick A.} and Bhatt, {Deepak L.}",
note = "Funding Information: ESB has received speaker honoraria from St Jude Medical and Terumo, and research support from Abbott Vascular and InfraRedx. His spouse is an employee of Medtronic. He is the principal investigator of the Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA) trial ( NCT01121224 ), which is comparing bare-metal with drug-eluting stents in saphenous vein graft lesions. SB has received speaker honoraria from St Jude Medical, Medtronic, and Johnson & Johnson, and research support from Boston Scientific and The Medicines Company. KAS has received research support from Abbott Vascular and Siemens Medical Systems; owns stock options in Revascular Therapeutics; and has intellectual property rights licensed by SurgiVision. DLB has received research grants from AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, Sanofi-Aventis, and The Medicines Company. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2012",
month = feb,
doi = "10.1016/S0140-6736(12)60264-5",
language = "English (US)",
volume = "379",
pages = "615",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9816",
}